Kara Cicero

Dr. Kara Cicero serves as Assistant Professor at Fred Hutchinson Cancer Center's Clinical Research Division and the University of Washington School of Medicine's Division of Hematology and Oncology. Her work bridges clinical hematology-oncology with global health equity initiatives, specializing in plasma cell disorders including multiple myeloma and AL amyloidosis.

Her educational background includes:

• MD from Tulane University School of Medicine
• MPH in Global Health Systems and Development from Tulane University School of Public Health and Tropical Medicine
• Fellowship in Hematology and Medical Oncology at Columbia University
• Residency in Internal Medicine at Columbia University
• BS in Human Development from Cornell University

Dr. Cicero's research program targets cancer disparities through global oncology frameworks, emphasizing community-based interventions to improve access for underserved populations. Her clinical investigations focus on therapeutic optimization for plasma cell malignancies within diverse demographic contexts, integrating public health methodologies with clinical oncology practice.

Her scientific recognition includes:

• American Society of Clinical Oncology Young Investigator Award (2022)
• American Association for Cancer Research Cancer Disparities Fellowship (2022)

Board-certified in Hematology (2023) and Internal Medicine (2020) by the American Board of Internal Medicine, she maintains active clinical practice while leading research within Fred Hutch's Clinical Research Division infrastructure. Her collaborative work spans international partnerships focused on resource-limited oncology settings.